Cardiovascular risk score predicts multiple eye diseases
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Jun-2026 17:16 ET (15-Jun-2026 21:16 GMT/UTC)
When a person suffers a stroke, physicians must restore blood flow to the brain as quickly as possible to save their life. But, ironically, that life-saving rush of blood can also trigger a second wave of damage — killing brain cells, fueling inflammation and increasing the odds of long-term disability.
Now, Northwestern University scientists have developed an injectable regenerative nanomaterial that helps protect the brain during this vulnerable window.
In a new preclinical study, the team delivered a single intravenous dose, immediately after restoring blood flow, in a mouse model of ischemic stroke, the most common type of stroke. The therapy successfully crossed the blood-brain barrier — a major challenge for most drugs — to reach and repair brain tissue. The material significantly reduced brain damage and showed no signs of side effects or organ toxicity.
A new study shows that millions of Britons could be ready to swap imported fish for home caught favourites like sardines, sprats and anchovies.
The new report reveals that more than 40 per cent of consumers are willing to experiment with fish they’ve never tried before. The study suggests the UK is overlooking a major opportunity to improve national health and bolster local economies by embracing its own rich stocks of small, nutritious fish.
And the team say that now is the perfect time for Britain to rediscover its local seafood.
Vaccinating women during pregnancy leads to the transfer of antibodies to their newborns. These antibodies were detected not only in blood, but also in the nasal mucosa, the site where whooping cough bacteria enter the body. This has been shown by international research led by Radboud university medical center. ‘The fact that these antibodies reach the nasal mucosa has not been demonstrated before and highlights how effective this vaccination is’.
A team of scientists and physicians at Mass General Brigham has developed a single-dose oral cholera vaccine and tested it in a phase 1 clinical trial, with results published in The Lancet Infectious Diseases.
A new study from UCLA Health has found that long-term residential exposure to the pesticide chlorpyrifos is associated with more than a 2.5-fold increased risk of developing Parkinson's disease. The research, published in the journal Molecular Neurodegeneration, combines human population data with laboratory experiments showing how the pesticide damages dopamine-producing brain cells, providing biological evidence for the link.